SCHEMBL9970808

SCHEMBL9970808

COc1cc(OC)cc(C(=O)Oc2cc(OC(=O)c3cc(OC)cc(OC)c3)cc(OC(=O)c3cc(OC)cc(OC)c3)c2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.53
MEN1 O00255 2/20 0.53
ESR1 P03372 1/20 0.51
ESR2 Q92731 1/20 0.51
ALDH1A1 P00352 1/20 0.50
LMNA P02545 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
POLB P06746 2/20 0.47
KDM4E B2RXH2 2/20 0.47
ABCG2 Q9UNQ0 1/20 0.47
GAA P10253 1/20 0.47
MAPT P10636 1/20 0.46
RXRA P19793 1/20 0.46
CES2 O00748 1/20 0.45
CES1 P23141 1/20 0.45
PRSS1 P07477 1/20 0.45
ACR P10323 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9967360 0.90 KMT2A (0.63) KMT2AMEN1ESR1ESR2ALDH1A1
Methyl 3,5-Dimethoxybenzoate SCHEMBL204865 0.84 CA1 (0.61) KMT2AMEN1ALDH1A1LMNASMN1; SMN2
SCHEMBL11031812 0.82 CA1 (0.57) KMT2AMEN1ESR1ESR2LMNA
SCHEMBL16533898 0.82 CA1 (0.50) KMT2AMEN1ALDH1A1LMNASMN1; SMN2
SCHEMBL7954384 0.82 ALDH1A1 (0.50) KMT2AMEN1ALDH1A1CYP1A2CYP2C9
SCHEMBL9905977 0.80 THRB (0.56) KMT2AESR1ESR2ALDH1A1LMNA
SCHEMBL5292727 0.80 HPGD (0.56) KMT2AMEN1ALDH1A1LMNACYP1A2
SCHEMBL25508540 0.80 CES2 (0.64) KMT2AMEN1ALDH1A1CYP1A2CYP2C9
SCHEMBL27775552 0.80 KDM4E (0.50) KMT2AMEN1ALDH1A1KDM4EABCG2
SCHEMBL26480089 0.80 ALDH1A1 (0.48) KMT2AMEN1ALDH1A1SMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120156614-A1 Novel Phenol Compounds and Positive Photosensitive Resin Composition Including the Same SAMSUNG ELECTRONICS CO., LTD. (KR) 2012-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120156614-A1 Novel Phenol Compounds and Positive Photosensitive Resin Composition Including the Same SUN2, TYR, PSMD2 KMT2A 595/4885MEN1 4379/4885ESR1 298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.